Enhancing Activity of Bortezomib Against Multiple Myeloma (MM) through Inhibition of Interleukin (IL)-6 Signaling: A Role for Repression of Myeloid Cell Leukemia (Mcl)-1.
- Resource Type
- Abstract
- Source
- In
Blood 16 November 2006 108(11):3414-3414 - Subject
- Language
- ISSN
- 0006-4971